Studies of Plexin-B3 have demonstrated that Plexin-B3 regulates Rac activation in a ligand-dependent manner in glioma cells by binding to RhoGDI, which prevents Rac activation and reduces cell motility [66]. This evidence concerns the gene ARHGDIA and central nervous system cancer.